CADL:NASDAQ, Candel Therapeutics, Inc.
CADL stock overview
Candel Therapeutics, Inc. (CADL:NASDAQ) closed at $5.04 on November 20, 2026,
down 1.75% on the day.
The stock trades 64.0% below its 52-week high of $14.00
and 15.9% above its 52-week low of $4.35.
Over the past year, it gained 11.3%.
Candel Therapeutics, Inc. is part of the Health Care sector.
Key figures
- Price
- $5.04
- Day change
- -1.75%
- Volume
- 1,722,327
- Average volume
- 1,258,337
- Market cap
- 395M+
- 52-week range
- $4.35 – $14.00
- 50-day average
- $9.21
- 200-day average
- $8.40
Price action over the past year
In 252 trading sessions since November 20, 2025, CADL closed higher on 121 days (48%).
Its best day was April 17, 2026 (+23.45%) and its worst was November 13, 2026 (-26.10%).
The stock moved 10% or more in a single session 12 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
CADL news
-
Nov 19, 2026:
Candel Therapeutics (CADL) Faces Investor Scrutiny After Surprise BLA Delay Drives Stock 26% Lower - Hagens Berman
-
Nov 16, 2026:
PRISM MarketView Highlights Seven Small-Cap Lung Cancer Developers for Lung Cancer Awareness Month
-
Nov 15, 2026:
Candel Therapeutics (CADL) Stock Fair Value Moves Lower After Analysts Cut Targets
-
Nov 13, 2026:
CADL Stock Heads For Worst Ever Session — Stifel Expects Prostate Cancer Drug Launch To Be Pushed to Mid-2028
-
Nov 13, 2026:
CADL Stock Heads For Worst Ever Session Stifel Expects Prostate Cancer Drug Launch To Be Pushed to Mid-2028
-
Nov 13, 2026:
Candel Therapeutics stock plummets 35% on prostate cancer BLA delay
-
Nov 13, 2026:
Futures Edge Lower As NVDA Fallout Unsettles Tech Stocks — SLS, AMAT, CSCO, CADL Stocks In Focus
-
Nov 13, 2026:
Futures Edge Lower As NVDA Fallout Unsettles Tech Stocks SLS, AMAT, CSCO, CADL Stocks In Focus
About Candel Therapeutics, Inc.
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
Similar stocks
Find more stocks like CADL with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.